C17.1
Malignant neoplasm of jejunum
Clinical Classification Guidelines
Medical Intelligence & Overview
Malignant neoplasm of the jejunum refers to a type of cancer that originates in the jejunum, which is a section of the small intestine situated between the duodenum and ileum. This rare form of gastrointestinal cancer involves abnormal, uncontrollable cell growth in the jejunum's lining or tissues. Early detection is crucial, but due to its location and often subtle symptoms, it may be diagnosed at an advanced stage. Treatment options typically include surgery, chemotherapy, or a combination of both, aimed at removing the tumor and preventing spread.
Causes & Symptoms
Clinical Causes: Genetic predispositions, including inherited syndromes Chronic inflammation of the small intestine History of radiation or certain chemotherapy treatments Lifestyle factors such as smoking and poor diet Exposure to carcinogens, potentially linked to environmental factors
Key Symptoms: Unexplained weight loss Abdominal pain or cramping Nausea and vomiting Digestive disturbances such as diarrhea or constipation Gastrointestinal bleeding, resulting in anemia or dark stools Palpable abdominal mass in some cases Weakness and fatigue
Diagnostic & Treatment
Diagnosis Path: Detection of a malignant neoplasm in the jejunum often involves multiple diagnostic approaches, including endoscopy, imaging techniques (such as CT scans or MRI), and biopsy procedures. These tools help determine the size, location, and extent of tumor spread. Laboratory tests may reveal anemia or other related abnormalities. Due to its rarity and deep location within the abdomen, diagnosing jejunal cancer can be challenging, requiring a thorough evaluation by specialists.
Treatment Protocols: Treatment strategies primarily focus on removing the tumor and controlling spread. Surgical resection of the affected jejunal segment is typically the first-line approach. Depending on the tumor's size, location, and stage, additional therapies might include chemotherapy or targeted therapy to reduce the risk of recurrence. Supportive care to manage symptoms and maintain nutritional status is also essential. The choice of treatment varies based on individual patient factors and disease progression.
Clinical Advice & FAQs
Billing Guidance
Is C17.1 a billable ICD-10 code?
Yes, C17.1 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C17.1?
Clinical documentation must specify the nature of Malignant neoplasm of jejunum and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
